Kras Status and Efficacy in the Crystal Study: 1st-line Treatment of Patients with Metastatic Colorectal Cancer (mcrc) Receiving Folfiri with Or Without Cetuximab

Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

Contributors

  • E. Van Cutsem - , KU Leuven (Author)
  • I. Lang - , National Institute of Oncology (Author)
  • G. D'Haens - , Imelda Hospital (Author)
  • V. Moiseyenko - , N.N. Petrov Research Institute of Oncology (Author)
  • J. Zaluski - , Greater Poland Cancer Centre (Author)
  • G. Folprecht - , Department of Internal Medicine I (Author)
  • S. Tejpar - , KU Leuven (Author)
  • J. Nippgen - , Merck KGaA (Author)
  • C. Stroh - , Merck KGaA (Author)
  • P. Rougier - , INSERM - Institut national de la santé et de la recherche médicale (Author)

Details

Original languageEnglish
Pages (from-to)44-45
Number of pages2
JournalAnnals of oncology
Volume19
Issue numberSuppl 8
Publication statusPublished - Sept 2008
Peer-reviewedYes

Conference

Title33rd European-Society-for-Medical-Oncology Congress
Duration12 - 16 September 2008
CityStockholm
CountrySweden

External IDs

WOS 000259973300071
ORCID /0000-0002-9321-9911/work/142252020

Keywords

Sustainable Development Goals